Search research articles
Contact Us
Filters
Showing results (221-230 of 426) with videos related to
Page
of 43
Sort By:
Leukemia
|
May 1, 1989
Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195
M Tanimoto, D A Scheinberg, C Cordon-Cardo, et al.
Neuropediatrics
|
January 7, 2011
Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics
N Snyman, J R Egan, K London, et al.
Bioconjugate Chemistry
|
October 16, 2007
Enhanced retention of the alpha-particle-emitting daughters of Actinium-225 by liposome carriers
Stavroula Sofou, Barry J Kappel, Jaspreet S Jaggi, et al.
Blood
|
May 1, 1996
Specific human cellular immunity to bcr-abl oncogene-derived peptides
M Bocchia, T Korontsvit, Q Xu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 22, 2004
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates
Matthias Miederer, Michael R McDevitt, George Sgouros, et al.
The Journal of Experimental Medicine
|
October 1, 1992
Engineered humanized dimeric forms of IgG are more effective antibodies
P C Caron, W Laird, M S Co, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 2006
Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys
Jaspreet Singh Jaggi, Surya V Seshan, Michael R McDevitt, et al.
Current Opinion in Biotechnology
|
February 11, 2017
Advances in the clinical translation of nanotechnology
David A Scheinberg, Jan Grimm, Daniel A Heller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2004
Engineered liposomes for potential alpha-particle therapy of metastatic cancer
Stavroula Sofou, James L Thomas, Hung-yin Lin, et al.
Biochemical and Biophysical Research Communications
|
November 26, 2003
A new human peptide deformylase inhibitable by actinonin
Mona D Lee, Christophe Antczak, Yueming Li, et al.
Page
of 43
Search research articles
Search
Showing results (221-230 of 426) with videos related to
Sort By:
Page
of 43
Leukemia
|
May 1, 1989
Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195
M Tanimoto, D A Scheinberg, C Cordon-Cardo, et al.
Neuropediatrics
|
January 7, 2011
Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics
N Snyman, J R Egan, K London, et al.
Bioconjugate Chemistry
|
October 16, 2007
Enhanced retention of the alpha-particle-emitting daughters of Actinium-225 by liposome carriers
Stavroula Sofou, Barry J Kappel, Jaspreet S Jaggi, et al.
Blood
|
May 1, 1996
Specific human cellular immunity to bcr-abl oncogene-derived peptides
M Bocchia, T Korontsvit, Q Xu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 22, 2004
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates
Matthias Miederer, Michael R McDevitt, George Sgouros, et al.
The Journal of Experimental Medicine
|
October 1, 1992
Engineered humanized dimeric forms of IgG are more effective antibodies
P C Caron, W Laird, M S Co, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 2006
Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys
Jaspreet Singh Jaggi, Surya V Seshan, Michael R McDevitt, et al.
Current Opinion in Biotechnology
|
February 11, 2017
Advances in the clinical translation of nanotechnology
David A Scheinberg, Jan Grimm, Daniel A Heller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2004
Engineered liposomes for potential alpha-particle therapy of metastatic cancer
Stavroula Sofou, James L Thomas, Hung-yin Lin, et al.
Biochemical and Biophysical Research Communications
|
November 26, 2003
A new human peptide deformylase inhibitable by actinonin
Mona D Lee, Christophe Antczak, Yueming Li, et al.
Page
of 43